Another recent study from Italy published by Gasperini et al. [37] concerning MDR UTI bacteria in geriatric population also highlighted the increased uropathogen resistance for quinolones-levofloxacin (R = 80.0%) and ciprofloxacin (R = 55.3%); cephalosporins-cefepime, cefotaxime, and ceftazidime (R = 45.8%, 59.4%, and 51.6%, respectively); and aminopenicillin with beta lactamase inhibitor-amoxicillin/clavulanic acid (R = 50.0%) was noted. The gene discussed is LACTB; the disease is bacterial urinary tract infection.